Protocol - Current Contraception Use - Female
The woman is asked if she is pregnant, her general sexual intercourse frequency of this calendar year, whether she or her partner are physically able to conceive, and the type of contraceptive used.
1. Are you pregnant now?
2. Have you ever had both of your tubes tied, cut, or removed? This procedure is often called a tubal ligation or tubal sterilization.
1[ ]Yes (questions complete)
3. Have you ever had a hysterectomy, that is, surgery to remove your uterus?
1[ ]Yes (questions complete)
4. Has (HUSBAND/PARTNER) ever had a vasectomy or any other operation that would make it impossible for him to father a baby in the future?
1[ ]Yes (questions complete)
5. (If currently sexually active and not sterilized) The last time that you had sexual intercourse, did you or your partner use any method of contraception?
2[ ]No (questions complete)
6. (If used contraception at last intercourse) What contraceptive method did you or your partner use?
3[ ]Birth control pills
5[ ]Partner’s vasectomy
6[ ]Female sterilizing operation, such as tubal sterilization and hysterectomy
7[ ]Withdrawal, pulling out
8[ ]Depo-Provera™, injectables
9[ ]Hormonal implant (Norplant™ , Implanon™, or Nexplanon™)
10[ ]Calendar rhythm, Standard Days, or Cycle Beads method
11[ ]Safe period by temperature or cervical mucus test (Two Day, Billings Ovulation, or Sympto-thermal Method)
13[ ]Female condom, vaginal pouch
15[ ]Jelly or cream
16[ ]Cervical cap
17[ ]Suppository, insert
18[ ]Today™ sponge
19[ ]Intrauterine device (IUD), coil, loop (Mirena, Paraguard)
20[ ]Emergency Contraception
21[ ]Other method -- specify
22[ ]Respondent was sterile
23[ ]Respondent’s partner was sterile
24[ ]Lunelle™ injectable (monthly shot)*
25[ ]Contraceptive patch
26[ ]Vaginal contraceptive ring
*Lunelle is no longer available in the U.S.
Depo-Provera® is a registered trademark of Pfizer Inc.; Norplant® is the registered trademark of the Population Council for levonorgestrel-releasing capsule implants for protection against pregnancy; Today® is a registered trademark of Alvogen Group, Inc.
Personnel and Training Required
The interviewer must be trained to conduct personal interviews with individuals from the general population. The interviewer must be trained and found to be competent (i.e., tested by an expert) at the completion of personal interviews. The interviewer should be trained to prompt participants further if a "don’t know" response is provided.
If a computer-assisted instrument is used, computer software may be necessary to develop the instrument. The interviewer will require a laptop computer/handheld computer to administer a computer-assisted questionnaire.
|Specialized requirements for biospecimen collection||No|
|Average time of greater than 15 minutes in an unaffected individual||No|
Mode of Administration
The National Survey of Family Growth (NSFG) sample represents the household population of the United States, 15-44 years of age.
This approach, which has been utilized in several national surveys, provides for minimal burden because it does not require extensive questioning.
|caDSR Common Data Elements (CDE)||Femal current Contraception Use Assessment Description Text||3007431||CDE Browser|
Process and Review
The Expert Review Panel #5 (ERP 5) reviewed the measures in the Reproductive Health domain.
Guidance from ERP 5 includes:
· Changed the name of the measure
· Replaced protocol
· New Data Dictionary
Back-compatible: The original protocol from the National Survey of Family Growth (NSFG) 2003 Cycle 6, Womens Health Initiative 1998, and LIFE Study was updated to NSFG 2013-2015. The new protocol is a single source and includes more current contraceptive methods. There are changes to the Data Dictionary, previous version of the Data Dictionary and Variable mapping in Toolkit archive (http://www.phenxtoolkit.org/domains/view/100000#tab5content)
Previous version in Toolkit archive (link).
Protocol Name from Source
National Survey of Family Growth (NFSG), 2013-2015
Centers for Disease Control and Prevention (CDC). National Survey of Family Growth, 2013-2015, BA-2, DA-1, DA-2, DA-8, EF-1, EF-2
Lepkowski, J. M., Mosher, W. D., Davis, K. E., Groves, R. M., van Hoewyk, J., & Willem, J. (2006). National Survey of Family Growth, Cycle 6: Sample design, weighting, imputation, and variance estimation. Vital and Health Statistics, 2(142), 1-82.
Martinez, G. M., Chandra, A., Abma, J. C., Jones, J., & Mosher, W. D. (2006). Fertility, contraception, and fatherhood: Data on men and women from cycle 6 (2002) of the 2002 National Survey of Family Growth. Vital and Health Statistics, 23(26), 1-142.
|Variable Name||Variable ID||Variable Description||dbGaP Mapping|
|PX100303020000||Have you ever had both of your tubes tied, more||Variable Mapping|
|PX100303030000||Have you ever had a hysterectomy, that is, more||N/A|
|PX100303050000||(If currently sexually active and not more||N/A|
|PX100303060000||(If used contraception at last intercourse) more||N/A|
|PX100303040000||Has (HUSBAND/PARTNER) ever had a vasectomy more||N/A|
|PX100303010000||Are you pregnant now?||N/A|
Current Contraception Use
April 11, 2017
Questions to assess participants’ use of contraception.
The purpose of these questions is to determine the type of contraceptive methods used by both female and male study participants. Certain methods, such as hormonal contraceptives, may be associated with gene/environment factors. Contraceptive methods might also be of interest as they relate to risk of sexually transmitted diseases.
Reproductive health, contraceptive methods, birth control, National Survey of Family Growth, NSFG
|Protocol ID||Protocol Name|
|100301||Contraceptive Methods - Female|
|100302||Contraceptive Methods - Male|
|100303||Current Contraception Use - Female|
|100304||Current Contraception Use - Male|
There are no publications listed for this protocol.